Developer docs
API playgroundTry for free, no card

Search company profiles

Ziovision

Full company profile

uuid0003kl8

Namestring
Ziovision
Legal namestring
주식회사 지오비전 (ZIOVISION Co., Ltd.)
Websiteurl
ziovision.co.kr
Company typeenum
Private
Founded yearint
2020
Descriptiontext

Ziovision (지오비전) is a privately held South Korean AI company founded around 2020, headquartered at the Gangwon National University campus in Chuncheon, with a Seoul office in the Guro Digital Innovation Park. The company operates a dual-track product portfolio. Its Social Safety AI line addresses CCTV-heavy public safety workflows: Zio-Summary is an LLM-based video summarization system that condenses 10-hour video into 20-minute summaries and is described as Korea's only such system; ZioVIS is a GS-Certification-Grade-1 intelligent selective monitoring system; ZioKeeper detects suspected child abuse through emotion and behavior recognition and has been deployed by the Seoul Metropolitan Police Agency; and ZioEdge is an edge-device form factor for small-scale monitoring. Its Medical AI line includes ZioMed (deep-learning diagnostic imaging), AI CDSS (intensive care unit clinical decision support), Smart Hospital (patient safety management), and a ZIOMED sub-brand of regulated medical devices (TUBA for nasogastric tube insertion, DeepPU for pressure ulcer risk, DeepTDM for drug concentration prediction, FaBoA for medical imaging, and JointMLP for drug injection management). Multiple ZIOMED products hold Korean MFDS approvals, medical device GMP, ISO 13485, and ISO 9001 certifications, and ZIOMED TUBA was the second product approved under the Digital Medical Products Act.

Ziovision sells through a direct enterprise and government field sales motion, primarily to Korean public-sector buyers (police, regional governments, administrative agencies, defense), university hospitals, and the military. Distribution is anchored in government procurement channels and hospital-direct sales, with defense procurement accessed through the Gangwon Defense Venture Center. Pricing is not publicly disclosed and the company's revenue model centers on software licensing, subscriptions, and regulated medical device sales, with sales handled via sales@ziovision.co.kr. The company has raised approximately 15 billion KRW (~$2.6M USD) across multiple 2022-2024 Series A tranches led by Anda Asia Ventures, Honest Ventures, and the Korean Small Business Corporation, supplementing earlier TIPS Program support. It employs 11-50 staff and is led by CEO Kim Yun (김윤).

Strategically the company is in an early commercialization phase, with its first major public-sector contract (Seoul Metropolitan Police Agency) signed in May 2025, defense vertical expansion anchored by a October 2025 MOU with a national defense research institute, and US market entry supported by selection for the Global Innovation Special Zone program in October 2024. Research credibility is unusually strong for the size, including first place at ICCV AI City Challenge 2025 in multi-camera reasoning and 3D object tracking, and AAAI 2026 paper acceptance, but commercial revenue is not yet disclosed and the customer base remains narrow and concentrated.

Short descriptiontext

Ziovision is a South Korean AI company building video analytics and medical AI software for government public safety, defense, and hospital customers. Its products include the Zio-Summary LLM-based video summarization system, ZioKeeper child abuse detection deployed by Seoul Police, and MFDS-cleared ZIOMED medical devices.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersGangneung, South Korea
HQ citystring
Gangneung
HQ countrystring
South Korea
HQ regionstring
Asia
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
AI video analytics, medical AI diagnostics, intelligent video surveillance, clinical decision support, computer vision software
Industry2 codes
PRIMARYHDAAAEAE
Video Surveillance & Security Analytics
SECONDARYHLACANAD
Software as a Medical Device (SaMD) – Clinical Decision & Diagnostic Software
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
NAICS code1 code
  • Software Publishers5132
SIC code1 code
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
AI Video Analytics and Medical AI Software
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1AI Software Licenses and Subscriptions
TypeSubscription Recurring
Description

Ziovision generates revenue through licensing and subscription of its AI software products including Zio-Summary, ZioVIS, ZioKeeper, ZioEdge, ZioMed, AI CDSS, and Smart Hospital. Medical AI devices such as ZIOMED TUBA, ZIOMED DeepPU, ZIOMED DeepTDM, and ZIOMED-JointMLP have received regulatory approvals and certifications enabling commercial revenue generation.

ziovision.co.kr
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 12 records shown
1Zio-Summary
Description

Video summarization system that condenses 10-hour videos into 20-minute summaries - Korea's only video summarization system

ziovision.co.kr
+11 more records
Core offering1 text field

Ziovision develops and sells AI-powered video analytics and medical AI software for two main segments: Social Safety AI (video summarization, intelligent surveillance, child abuse detection, edge-based monitoring) and Medical AI (medical imaging diagnostics, ICU clinical decision support, and patient safety management). The products are sold primarily to government agencies, hospitals, and defense organizations in South Korea through direct sales and procurement channels.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Zio-Summary reduces 10-hour video to 20-minute summary
Product overview1 text field

Ziovision offers a dual-track AI product portfolio spanning Social Safety AI and Medical AI. The Social Safety AI division includes Zio-Summary (video summarization system), ZioVIS (intelligent selective monitoring with GS Grade 1 certification), ZioKeeper (child abuse detection via emotion/behavior recognition), and ZioEdge (edge device-based monitoring). The Medical AI division encompasses ZioMed (AI diagnostic system), AI CDSS (clinical decision support for ICUs), and Smart Hospital (patient safety management). Ziovision has developed multiple specialized medical sub-products under the ZIOMED brand including DeepTDM (drug concentration prediction), DeepPU (pressure ulcer risk), TUBA (feeding tube detection), FaBoA (medical imaging analysis), and JointMLP (drug injection management).

Product and service12 records
1Zio-Summary (지오서머리)
2ZioVIS (지오비스)
CategorySocial Safety AI Software
Description

Intelligent selective monitoring system that instantly selects and monitors objects of interest from CCTV streams. Awarded GS Certification Grade 1. Deployed to government agencies for surveillance and public safety operations.

3ZioKeeper (지오지킴이)
CategorySocial Safety AI Software
Description

AI system that detects suspected child abuse situations through emotion and behavior recognition in video footage. Delivered to the Seoul Metropolitan Police Agency for child abuse video analysis.

4ZioEdge (지오엣지)
CategorySocial Safety AI Software
Description

AI-based individual and small-scale monitoring system using edge devices. Enables distributed AI surveillance for personal or small-scale deployments.

5ZioMed (지오메드)
CategoryMedical AI Software
Description

AI and deep learning-based medical diagnostic system encompassing multiple sub-products for facial bone fracture detection, pressure ulcer risk analysis, abnormal nasogastric tube insertion detection, drug concentration prediction, and medical image analysis. Used by hospitals and healthcare institutions.

6AI CDSS
CategoryMedical AI Software
Description

Artificial intelligence-based intensive care unit clinical decision support system for critically ill patients. Provides AI-driven decision support to ICU clinicians.

7Smart Hospital (스마트 병원)
CategoryMedical AI Software
Description

Patient safety management system for hospital environments, designed to monitor and manage patient safety in clinical settings.

8ZIOMED DeepTDM
CategoryMedical AI Software
Description

AI-based drug concentration prediction medical device that uses deep learning to predict drug concentration levels. Designated as an innovative medical device by Korean authorities.

9ZIOMED DeepPU
CategoryMedical AI Software
Description

Pressure ulcer occurrence risk analysis digital medical device using AI for hospital patient safety.

10ZIOMED TUBA
CategoryMedical AI Software
Description

AI-based software medical device for abnormal nasogastric (feeding) tube insertion detection. 2nd approval under Korea's Digital Medical Products Act.

11ZIOMED FaBoA
CategoryMedical AI Software
Description

Medical image analysis software for facial bone fracture detection using deep learning. Obtained medical device manufacturing certification.

12ZIOMED-JointMLP
CategoryMedical AI Software
Description

Drug injection management software using deep learning. Received Korea MFDS export approval for international distribution.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-10-01
Description

AI-based video analysis and defense application technology joint research MOU signed in October 2025 between Ziovision and the Kangwon National University Advanced Military Science and Technology Research Institute, focusing on AI-powered video analysis for defense scenarios.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-05-29
Description

MOU signed in May 2025 for joint commercialization of AI-based X-ray medical devices, combining Ziovision's AI technology with DR Tech's medical imaging hardware capabilities.

3Gangwon Defense Venture Center (강원국방벤처센터)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-03-18
Description

Ziovision selected as a partner company of the Gangwon Defense Venture Center, enabling participation in defense AI projects and military procurement programs.

ziovision.co.kr
4Global Innovation Special Zone Program (글로벌혁신특구)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-10-15
Description

Selected for the Global Innovation Special Zone program in October 2024 to accelerate US market entry with government support.

ziovision.co.kr
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-03-21
Description

Tripartite partnership with Kangwon National University Hospital and Gangdong Kyung Hee University Hospital for AI clinical decision support system development, leveraging hospital medical imaging data and clinical expertise.

6Gangdong Kyung Hee University Hospital (강동경희대학교병원)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-03-21
Description

Tripartite partnership with Kangwon National University Hospital and Gangdong Kyung Hee University Hospital for AI clinical decision support system development.

ziovision.co.kr
7Neo Able (네오에이블)
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2021-12-20
Description

Cooperation agreement signed with Neo Able for collaborative partnership.

ziovision.co.kr
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-07-07
Description

Medical imaging AI deep learning research collaboration agreement signed in July 2020 with Kangwon National University Hospital, providing access to medical imaging data for AI model training.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Oosto provides AI video analytics including facial recognition, behavior detection, and watchlist alerting for security and public-safety deployments — closely comparable to ZioKeeper's emotion and behavior recognition for child abuse detection.

TypeDirect peer
Description

IronYun / Vaidio offers an AI video analytics platform covering object detection, behavior analysis, LPR, and people counting — directly parallel to Ziovision's social-safety AI feature set including behavior and emotion recognition.

TypeBroad incumbent
Description

Hikvision is the world's largest CCTV and video-surveillance vendor, embedding AI analytics across its hardware-software stack — a broad incumbent whose AI capabilities overlap with Ziovision's CCTV-analytics products.

TypeDirect peer
Description

BriefCam is one of the closest direct peers: it specializes in AI-powered video analytics and video summarization for surveillance use cases — directly mirroring Ziovision's Zio-Summary and ZioVIS value propositions for security and public-safety customers.

TypeBroad incumbent
Description

SenseTime is a broad AI incumbent offering large-scale computer vision and video analytics for smart-city and surveillance applications, with substantially more capital and global reach than Ziovision's focused social-safety AI line.

TypeDirect peer
Description

Lunit is a Korean medical-AI company specializing in AI-powered imaging analysis for radiology and pathology, sharing Ziovision's ZioMed focus on CT, X-ray, and ultrasound diagnostic AI for hospitals.

TypeDirect peer
Description

Agent Vi is an established AI video analytics vendor offering real-time anomaly detection, object tracking, and search across CCTV networks — directly comparable to Ziovision's social-safety product suite.

TypeDirect peer
Description

Ambient.ai applies computer-vision AI to physical security camera feeds for threat detection and incident response in enterprise and government settings, sharing Ziovision's AI-on-CCTV positioning for public safety.

TypeDirect peer
Description

VUNO is a Korean medical-AI vendor with MFDS-cleared clinical decision support and imaging products — closely comparable to Ziovision's AI CDSS and ZIOMED portfolio serving Korean hospital customers.

TypeDirect peer
Description

Verkada combines cloud-managed physical security hardware with built-in AI video analytics for enterprises and public institutions — overlapping with Ziovision's intelligent selective monitoring (ZioVIS) and edge-based surveillance (ZioEdge).

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability9 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature8 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors5 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Ziovision

AI Video Analytics and Medical AI Softwareziovision.co.kr

Ziovision is a South Korean AI company building video analytics and medical AI software for government public safety, defense, and hospital customers. Its products include the Zio-Summary LLM-based video summarization system, ZioKeeper child abuse detection deployed by Seoul Police, and MFDS-cleared ZIOMED medical devices.

What Ziovision does

Ziovision (지오비전) is a privately held South Korean AI company founded around 2020, headquartered at the Gangwon National University campus in Chuncheon, with a Seoul office in the Guro Digital Innovation Park. The company operates a dual-track product portfolio. Its Social Safety AI line addresses CCTV-heavy public safety workflows: Zio-Summary is an LLM-based video summarization system that condenses 10-hour video into 20-minute summaries and is described as Korea's only such system; ZioVIS is a GS-Certification-Grade-1 intelligent selective monitoring system; ZioKeeper detects suspected child abuse through emotion and behavior recognition and has been deployed by the Seoul Metropolitan Police Agency; and ZioEdge is an edge-device form factor for small-scale monitoring. Its Medical AI line includes ZioMed (deep-learning diagnostic imaging), AI CDSS (intensive care unit clinical decision support), Smart Hospital (patient safety management), and a ZIOMED sub-brand of regulated medical devices (TUBA for nasogastric tube insertion, DeepPU for pressure ulcer risk, DeepTDM for drug concentration prediction, FaBoA for medical imaging, and JointMLP for drug injection management). Multiple ZIOMED products hold Korean MFDS approvals, medical device GMP, ISO 13485, and ISO 9001 certifications, and ZIOMED TUBA was the second product approved under the Digital Medical Products Act.

Ziovision sells through a direct enterprise and government field sales motion, primarily to Korean public-sector buyers (police, regional governments, administrative agencies, defense), university hospitals, and the military. Distribution is anchored in government procurement channels and hospital-direct sales, with defense procurement accessed through the Gangwon Defense Venture Center. Pricing is not publicly disclosed and the company's revenue model centers on software licensing, subscriptions, and regulated medical device sales, with sales handled via sales@ziovision.co.kr. The company has raised approximately 15 billion KRW (~$2.6M USD) across multiple 2022-2024 Series A tranches led by Anda Asia Ventures, Honest Ventures, and the Korean Small Business Corporation, supplementing earlier TIPS Program support. It employs 11-50 staff and is led by CEO Kim Yun (김윤).

Strategically the company is in an early commercialization phase, with its first major public-sector contract (Seoul Metropolitan Police Agency) signed in May 2025, defense vertical expansion anchored by a October 2025 MOU with a national defense research institute, and US market entry supported by selection for the Global Innovation Special Zone program in October 2024. Research credibility is unusually strong for the size, including first place at ICCV AI City Challenge 2025 in multi-camera reasoning and 3D object tracking, and AAAI 2026 paper acceptance, but commercial revenue is not yet disclosed and the customer base remains narrow and concentrated.

Ziovision firmographics

Firmographics
Name
Ziovision
Legal name
주식회사 지오비전 (ZIOVISION Co., Ltd.)
Website
https://ziovision.co.kr
Company type
Private
Founded year
2020
Operating status
Operating
Headcount range
11–50 employees
Short description
Ziovision is a South Korean AI company building video analytics and medical AI software for government public safety, defense, and hospital customers. Its products include the Zio-Summary LLM-based video summarization system, ZioKeeper child abuse detection deployed by Seoul Police, and MFDS-cleared ZIOMED medical devices.
Ownership category
akta.pro rank

Ziovision industry classification

Industry
Product category
AI Video Analytics and Medical AI Software
NAICS
Software Publishers (5132)
SIC
Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHDAAAEAE
Video Surveillance & Security Analytics
SECONDARYHLACANAD
Software as a Medical Device (SaMD) – Clinical Decision & Diagnostic Software
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)

Keywords

  • AI video analytics
  • Medical AI diagnostics
  • Intelligent video surveillance
  • Clinical decision support
  • Computer vision software

Where Ziovision is headquartered

Location

Headquarters

HQ city
Gangneung
HQ country
South Korea
HQ region
Asia

Offices2 records

Markets served

Ziovision business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain

Revenue model

  1. AI Software Licenses and Subscriptions: Ziovision generates revenue through licensing and subscription of its AI software products including Zio-Summary, ZioVIS, ZioKeeper, ZioEdge, ZioMed, AI CDSS, and Smart Hospital. Medical AI devices such as ZIOMED TUBA, ZIOMED DeepPU, ZIOMED DeepTDM, and ZIOMED-JointMLP have received regulatory approvals and certifications enabling commercial revenue generation.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Ziovision product offering

Product offering

Core offering

Ziovision develops and sells AI-powered video analytics and medical AI software for two main segments: Social Safety AI (video summarization, intelligent surveillance, child abuse detection, edge-based monitoring) and Medical AI (medical imaging diagnostics, ICU clinical decision support, and patient safety management). The products are sold primarily to government agencies, hospitals, and defense organizations in South Korea through direct sales and procurement channels.

Product overview

Ziovision offers a dual-track AI product portfolio spanning Social Safety AI and Medical AI. The Social Safety AI division includes Zio-Summary (video summarization system), ZioVIS (intelligent selective monitoring with GS Grade 1 certification), ZioKeeper (child abuse detection via emotion/behavior recognition), and ZioEdge (edge device-based monitoring). The Medical AI division encompasses ZioMed (AI diagnostic system), AI CDSS (clinical decision support for ICUs), and Smart Hospital (patient safety management). Ziovision has developed multiple specialized medical sub-products under the ZIOMED brand including DeepTDM (drug concentration prediction), DeepPU (pressure ulcer risk), TUBA (feeding tube detection), FaBoA (medical imaging analysis), and JointMLP (drug injection management).

Differentiator

Problem solved

Functional benefit

Brands

  • Zio-Summary: Video summarization system that condenses 10-hour videos into 20-minute summaries - Korea's only video summarization system
  • ZioVIS
  • ZioKeeper
  • ZioEdge
  • ZioMed
  • AI CDSS
  • Smart Hospital
  • ZIOMED DeepPU
  • ZIOMED DeepTDM
  • ZIOMED TUBA
  • ZIOMED FaBoA
  • ZIOMED-JointMLP

Products and services

  • Zio-Summary (지오서머리)
  • ZioVIS (지오비스) Intelligent selective monitoring system that instantly selects and monitors objects of interest from CCTV streams. Awarded GS Certification Grade 1. Deployed to government agencies for surveillance and public safety operations.
  • ZioKeeper (지오지킴이) AI system that detects suspected child abuse situations through emotion and behavior recognition in video footage. Delivered to the Seoul Metropolitan Police Agency for child abuse video analysis.
  • ZioEdge (지오엣지) AI-based individual and small-scale monitoring system using edge devices. Enables distributed AI surveillance for personal or small-scale deployments.
  • ZioMed (지오메드) AI and deep learning-based medical diagnostic system encompassing multiple sub-products for facial bone fracture detection, pressure ulcer risk analysis, abnormal nasogastric tube insertion detection, drug concentration prediction, and medical image analysis. Used by hospitals and healthcare institutions.
  • AI CDSS Artificial intelligence-based intensive care unit clinical decision support system for critically ill patients. Provides AI-driven decision support to ICU clinicians.
  • Smart Hospital (스마트 병원) Patient safety management system for hospital environments, designed to monitor and manage patient safety in clinical settings.
  • ZIOMED DeepTDM AI-based drug concentration prediction medical device that uses deep learning to predict drug concentration levels. Designated as an innovative medical device by Korean authorities.
  • ZIOMED DeepPU Pressure ulcer occurrence risk analysis digital medical device using AI for hospital patient safety.
  • ZIOMED TUBA AI-based software medical device for abnormal nasogastric (feeding) tube insertion detection. 2nd approval under Korea's Digital Medical Products Act.
  • ZIOMED FaBoA Medical image analysis software for facial bone fracture detection using deep learning. Obtained medical device manufacturing certification.
  • ZIOMED-JointMLP Drug injection management software using deep learning. Received Korea MFDS export approval for international distribution.

Quantifiable outcome

  • Zio-Summary reduces 10-hour video to 20-minute summary

Companies that use Ziovision

Customer profile

Named customers7 records

Segments3 records

Ideal customer profiles3 records

Ziovision technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability9 records

Feature8 records

Ziovision partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core and minor.

  • Kangwon National University Advanced Military Science and Technology Research Institute (강원대학교 첨단군사과학기술연구소)coreStrategic or Co-development Partner · 1 October 2025AI-based video analysis and defense application technology joint research MOU signed in October 2025 between Ziovision and the Kangwon National University Advanced Military Science and Technology Research Institute, focusing on AI-powered video analysis for defense scenarios.
  • DR Tech (디알텍)coreStrategic or Co-development Partner · 29 May 2025MOU signed in May 2025 for joint commercialization of AI-based X-ray medical devices, combining Ziovision's AI technology with DR Tech's medical imaging hardware capabilities.
  • Gangwon Defense Venture Center (강원국방벤처센터)coreStrategic or Co-development Partner · 18 March 2025Ziovision selected as a partner company of the Gangwon Defense Venture Center, enabling participation in defense AI projects and military procurement programs.
  • Global Innovation Special Zone Program (글로벌혁신특구)coreStrategic or Co-development Partner · 15 October 2024Selected for the Global Innovation Special Zone program in October 2024 to accelerate US market entry with government support.
  • Kangwon National University Hospital (강원대학교병원)coreStrategic or Co-development Partner · 21 March 2024Tripartite partnership with Kangwon National University Hospital and Gangdong Kyung Hee University Hospital for AI clinical decision support system development, leveraging hospital medical imaging data and clinical expertise.
  • Gangdong Kyung Hee University Hospital (강동경희대학교병원)coreStrategic or Co-development Partner · 21 March 2024Tripartite partnership with Kangwon National University Hospital and Gangdong Kyung Hee University Hospital for AI clinical decision support system development.
  • Neo Able (네오에이블)minorStrategic or Co-development Partner · 20 December 2021Cooperation agreement signed with Neo Able for collaborative partnership.
  • Kangwon National University Hospital (강원대학교병원)coreStrategic or Co-development Partner · 7 July 2020Medical imaging AI deep learning research collaboration agreement signed in July 2020 with Kangwon National University Hospital, providing access to medical imaging data for AI model training.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Ziovision competitors and assessment

Company assessment

Direct peers

  • Oosto (formerly AnyVision): Oosto provides AI video analytics including facial recognition, behavior detection, and watchlist alerting for security and public-safety deployments — closely comparable to ZioKeeper's emotion and behavior recognition for child abuse detection.
  • IronYun (Vaidio): IronYun / Vaidio offers an AI video analytics platform covering object detection, behavior analysis, LPR, and people counting — directly parallel to Ziovision's social-safety AI feature set including behavior and emotion recognition.
  • BriefCam: BriefCam is one of the closest direct peers: it specializes in AI-powered video analytics and video summarization for surveillance use cases — directly mirroring Ziovision's Zio-Summary and ZioVIS value propositions for security and public-safety customers.
  • Lunit: Lunit is a Korean medical-AI company specializing in AI-powered imaging analysis for radiology and pathology, sharing Ziovision's ZioMed focus on CT, X-ray, and ultrasound diagnostic AI for hospitals.
  • Agent Video Intelligence (Agent Vi): Agent Vi is an established AI video analytics vendor offering real-time anomaly detection, object tracking, and search across CCTV networks — directly comparable to Ziovision's social-safety product suite.
  • Ambient.ai: Ambient.ai applies computer-vision AI to physical security camera feeds for threat detection and incident response in enterprise and government settings, sharing Ziovision's AI-on-CCTV positioning for public safety.
  • VUNO: VUNO is a Korean medical-AI vendor with MFDS-cleared clinical decision support and imaging products — closely comparable to Ziovision's AI CDSS and ZIOMED portfolio serving Korean hospital customers.
  • Verkada: Verkada combines cloud-managed physical security hardware with built-in AI video analytics for enterprises and public institutions — overlapping with Ziovision's intelligent selective monitoring (ZioVIS) and edge-based surveillance (ZioEdge).

Broad incumbents

  • Hikvision: Hikvision is the world's largest CCTV and video-surveillance vendor, embedding AI analytics across its hardware-software stack — a broad incumbent whose AI capabilities overlap with Ziovision's CCTV-analytics products.
  • SenseTime: SenseTime is a broad AI incumbent offering large-scale computer vision and video analytics for smart-city and surveillance applications, with substantially more capital and global reach than Ziovision's focused social-safety AI line.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Ziovision social profiles

Digital presence

Ziovision compliance and trust

Trust signal

Compliance3 records

Ziovision financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Ziovision leadership team

Management profile

Number of profiles

Profiles3 records

Ziovision funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors5 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Ziovision M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ziovision

What does Ziovision do?

Ziovision develops and sells AI-powered video analytics and medical AI software for two main segments: Social Safety AI (video summarization, intelligent surveillance, child abuse detection, edge-based monitoring) and Medical AI (medical imaging diagnostics, ICU clinical decision support, and patient safety management). The products are sold primarily to government agencies, hospitals, and defense organizations in South Korea through direct sales and procurement channels.

Is Ziovision a public or private company?

Ziovision is a private company. It is classified as venture growth investor backed and is currently operating.

When was Ziovision founded?

Ziovision was founded in 2020. It employs 11 to 50 people.

Where is Ziovision based?

Ziovision is headquartered in Gangneung, South Korea, in the Asia region.

How does Ziovision make money?

One revenue line is on record: AI Software Licenses and Subscriptions.

Who are Ziovision's main competitors?

Direct peers on record are Oosto (formerly AnyVision), IronYun (Vaidio), BriefCam, Lunit, Agent Video Intelligence (Agent Vi), Ambient.ai, VUNO and Verkada. Broad incumbents are Hikvision and SenseTime.

Does Ziovision have an API?

No public API is recorded for Ziovision.

What industry is Ziovision in?

Ziovision's product category is AI Video Analytics and Medical AI Software. Its primary akta.pro industry code is HDAAAEAE, Video Surveillance & Security Analytics, with a secondary code of HLACANAD, Software as a Medical Device (SaMD) – Clinical Decision & Diagnostic Software. Its NAICS code is 5132 and its SIC code is 3845.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales